These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 36017268)
21. Multivariable non-invasive association of isocitrate dehydrogenase mutational status in World Health Organization grade II and III gliomas with advanced magnetic resonance imaging T2 mapping techniques. Kern M; Auer TA; Fehrenbach U; Tanyildizi Y; Picht T; Misch M; Wiener E Neuroradiol J; 2020 Apr; 33(2):160-168. PubMed ID: 31957551 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2. Zhang K; Li C; Liu Y; Li L; Ma X; Meng X; Feng D Neuroradiology; 2007 Nov; 49(11):913-9. PubMed ID: 17763847 [TBL] [Abstract][Full Text] [Related]
23. MR textural analysis on T Rui W; Ren Y; Wang Y; Gao X; Xu X; Yao Z J Magn Reson Imaging; 2018 Jul; 48(1):74-83. PubMed ID: 29140606 [TBL] [Abstract][Full Text] [Related]
24. Radiological Characteristics and Natural History of Adult IDH-Wildtype Astrocytomas with TERT Promoter Mutations. Izquierdo C; Barritault M; Poncet D; Cartalat S; Joubert B; Bruna J; Jouanneau E; Guyotat J; Vasiljevic A; Fenouil T; Berthezène Y; Honnorat J; Meyronet D; Ducray F Neurosurgery; 2019 Sep; 85(3):E448-E456. PubMed ID: 30407589 [TBL] [Abstract][Full Text] [Related]
25. The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study. Corell A; Ferreyra Vega S; Hoefling N; Carstam L; Smits A; Olsson Bontell T; Björkman-Burtscher IM; Carén H; Jakola AS BMC Cancer; 2020 May; 20(1):450. PubMed ID: 32434559 [TBL] [Abstract][Full Text] [Related]
26. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT. Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723 [TBL] [Abstract][Full Text] [Related]
27. Whole-tumor histogram analysis of synthetic magnetic resonance imaging predicts isocitrate dehydrogenase mutation status in gliomas. Ge X; Gan T; Yang Z; Liu G; Hu W; Ma W; Bai Y; Xiong Y; Li M; Zhao J; Zhou L; Li J; Li D; Wang X; Zhang J Quant Imaging Med Surg; 2024 Mar; 14(3):2225-2239. PubMed ID: 38545061 [TBL] [Abstract][Full Text] [Related]
28. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI. Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279 [TBL] [Abstract][Full Text] [Related]
29. A Nomogram Modeling Zhou W; Zhou Z; Wen J; Xie F; Zhu Y; Zhang Z; Xiao J; Chen Y; Li M; Guan Y; Hua T Front Oncol; 2020; 10():1200. PubMed ID: 32850348 [No Abstract] [Full Text] [Related]
30. World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient. Maynard J; Okuchi S; Wastling S; Busaidi AA; Almossawi O; Mbatha W; Brandner S; Jaunmuktane Z; Koc AM; Mancini L; Jäger R; Thust S Radiology; 2020 Jul; 296(1):111-121. PubMed ID: 32315266 [TBL] [Abstract][Full Text] [Related]
31. Multiparametric Magnetic Resonance Imaging Correlates of Isocitrate Dehydrogenase Mutation in WHO high-Grade Astrocytomas. Sahu A; Patnam NG; Goda JS; Epari S; Sahay A; Mathew R; Choudhari AK; Desai SM; Dasgupta A; Chatterjee A; Pratishad P; Shetty P; Moiyadi AA; Gupta T J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675733 [TBL] [Abstract][Full Text] [Related]
32. Predicting Isocitrate Dehydrogenase Status in Non-Contrast-Enhanced Adult-Type Astrocytic Tumors Using Diffusion Tensor Imaging and Yasuda S; Yano H; Ikegame Y; Ikuta S; Maruyama T; Kumagai M; Muragaki Y; Iwama T; Shinoda J; Izumo T Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672625 [TBL] [Abstract][Full Text] [Related]